NR1H4 and Insulin resistance: In previous investigations, oral administration of FXR antagonist, T-β-MCA derivative or glycine-β-MCA, was found to decrease murine FXR signals in the ileum, that resulted in improvement of insulin resistance, obesity and liver steatosis associated with lower level of serum ceramide levels 18.